Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1980-09-29
1982-03-16
Cacciapaglia, Jr., Frank
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424319, A61K 31205, A61K 31195
Patent
active
043201458
ABSTRACT:
A glucose solution for drip phleboclysis characterized by the inclusion therein of L-carnitine is disclosed. The presence of L-carnitine improves the muscle tissue absorption and utilization of glucose, thus preventing excessive insulin secretion. This permits the utilization of 10% glucose solutions, and also in excess of 10%, without any risk for the patient even in the case of long-term treatment.
REFERENCES:
patent: 3830931 (1974-08-01), De Felice
patent: 3968241 (1976-07-01), De Felice
patent: 4194006 (1980-03-01), Cavazza
Strack et al., Hoppe Seyle Physiol. Chem. vol. 343, pp. 231-239 (1966).
Chem. Abstr. 78 (1973) entry 101978t.
Reynier et al. Revue Agressologie, 3(5), 711-719, (1962).
Madam et al., Drug Intelligence & Clin. Pharmacy, 10:684-696 (12/76).
Chem. Abstr. 82 (1975) entry 47745e.
Chem. Abstr. 85 (1976) entry 87551g.
Cacciapaglia, Jr. Frank
Collins Bruce M.
LandOfFree
Pharmaceutical composition for parenteral nutrition comprising L does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for parenteral nutrition comprising L, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for parenteral nutrition comprising L will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1641949